Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Drug Therapy | 2 |
| Adults | 1 |
| Developmental Disabilities | 1 |
| Drug Use | 1 |
| Foreign Countries | 1 |
| Guidelines | 1 |
| Incidence | 1 |
| Mental Retardation | 1 |
| Metabolism | 1 |
| Risk | 1 |
| Safety | 1 |
| More ▼ | |
Source
| Research in Developmental… | 2 |
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 2 |
Education Level
Audience
Location
| Norway | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkSabaawi, Mohamed; Singh, Nirbhay N.; de Leon, Jose – Research in Developmental Disabilities: A Multidisciplinary Journal, 2006
Clozapine is the most effective antipsychotic medication currently in use, but there has been a paucity of well-controlled research on its efficacy with people with developmental disabilities. We present a set of guidelines to ensure proper utilization of clozapine in individuals with developmental disabilities, because it can offer them…
Descriptors: Guidelines, Developmental Disabilities, Drug Therapy, Safety
Holden, Borge; Gitlesen, Jens Petter – Research in Developmental Disabilities: A Multidisciplinary Journal, 2004
People with mental retardation comprise an overmedicated population. Studies the last 20 years or so indicate that nearly 50% of people with mental retardation receiving care have been using psychotropic medication, in the treatment of psychiatric disorders and/or problem behaviours. The recent years guidelines for prescription of psychotropics…
Descriptors: Adults, Mental Retardation, Drug Therapy, Drug Use
